drugset / Trial / NCT00017108

Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia

NCT00017108

RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known which chlorambucil regimen is more effective in treating advanced chronic lymphocytic leukemia. PURPOSE: Randomized phase III trial to determine the effectiveness of different regimens of chlorambucil in treating patients who have advanced chronic lymphocytic leukemia.

Timeline

Start
2001-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorambucil Other / unclassified
Background Cyclophosphamide Other / unclassified Intravenous
Background Fludarabine Small molecule Intravenous

Indications